Cinemark Holdings, Inc. (CNK) Stock Forecast
Data as of May 2, 2026Communication Services · Current price $27.88 (-5.52%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 9, 2026 | Omar Mejias | Wells Fargo | $36.00 | +29.1% |
| Feb 19, 2026 | Michael Ng | Goldman Sachs | $22.00 | -21.1% |
| Jan 20, 2026 | Robert Fishman | MoffettNathanson | $30.00 | +7.6% |
| Dec 18, 2025 | Benjamin Swinburne | Morgan Stanley | $28.00 | +0.4% |
| Nov 5, 2025 | Eric Handler | Roth Capital | $35.00 | +25.5% |
| Jul 11, 2025 | Alicia Reese | Wedbush | $37.00 | +32.7% |
| Jul 10, 2025 | Bryan Kraft | Deutsche Bank | $36.00 | +29.1% |
| Oct 11, 2024 | Benjamin Swinburne | Morgan Stanley | $35.00 | +25.5% |
| Aug 5, 2024 | David Karnovsky | J.P. Morgan | $25.00 | -10.3% |
| Aug 5, 2024 | Chad Beynon | Macquarie | $30.00 | +7.6% |
| Aug 5, 2024 | James Goss | Barrington | $28.00 | +0.4% |
| Aug 5, 2024 | Eric Wold | B.Riley Financial | $31.00 | +11.2% |
| Aug 5, 2024 | Benjamin Swinburne | Morgan Stanley | $29.00 | +4.0% |
| Jul 18, 2024 | Benjamin Swinburne | Morgan Stanley | $26.00 | -6.7% |
| Jul 8, 2024 | Eric Wold | B.Riley Financial | $27.00 | -3.2% |
| Apr 10, 2024 | Eric Handler | Roth Capital | $19.00 | -31.9% |
| Apr 5, 2024 | Omar Mejias | Wells Fargo | $23.00 | -17.5% |
| Oct 17, 2023 | Eric Handler | Roth Capital | $20.00 | -28.3% |
| Jul 12, 2023 | Eric Wold | B.Riley Financial | $23.00 | -17.5% |
| May 8, 2023 | Douglas Mitchelson | Credit Suisse | $14.00 | -49.8% |
Top Analysts Covering CNK
CNK vs Sector & Market
| Metric | CNK | Communication Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.49 | 2.41 |
| Analyst Count | 12 | 10 | 18 |
| Target Upside | +13.6% | +120.8% | +14.9% |
| P/E Ratio | 28.45 | 4.28 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.36B | $3.43B | $3.50B | 9 |
| 2027-03-31 | $613M | $641M | $659M | 4 |
| 2027-06-30 | $980M | $1.02B | $1.05B | 6 |
| 2027-09-30 | $939M | $981M | $1.01B | 4 |
| 2027-12-31 | $886M | $926M | $952M | 7 |
| 2028-03-31 | $647M | $676M | $695M | 3 |
| 2028-06-30 | $1.03B | $1.07B | $1.10B | 5 |
| 2028-09-30 | $967M | $1.01B | $1.04B | 3 |
| 2028-12-31 | $937M | $980M | $1.01B | 6 |
| 2029-12-31 | $3.80B | $3.89B | $4.00B | 3 |
| 2030-12-31 | $3.94B | $4.03B | $4.15B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.93 | $2.09 | $2.22 | 8 |
| 2027-03-31 | $-0.15 | $-0.14 | $-0.13 | 3 |
| 2027-06-30 | $0.97 | $1.03 | $1.07 | 2 |
| 2027-09-30 | $0.86 | $0.91 | $0.94 | 2 |
| 2027-12-31 | $0.60 | $0.64 | $0.66 | 2 |
| 2028-03-31 | $-0.09 | $-0.09 | $-0.08 | 3 |
| 2028-06-30 | $1.07 | $1.13 | $1.18 | 6 |
| 2028-09-30 | $0.96 | $1.02 | $1.05 | 5 |
| 2028-12-31 | $0.75 | $0.80 | $0.83 | 5 |
| 2029-12-31 | $2.77 | $2.85 | $2.96 | 4 |
| 2030-12-31 | $2.99 | $3.08 | $3.20 | 2 |
Frequently Asked Questions
What is the analyst consensus for CNK?
The consensus among 12 analysts covering Cinemark Holdings, Inc. (CNK) is Buy with an average price target of $31.33.
What is the highest price target for CNK?
The highest price target for CNK is $37.00, set by Alicia Reese at Wedbush on 2025-07-11.
What is the lowest price target for CNK?
The lowest price target for CNK is $14.00, set by Douglas Mitchelson at Credit Suisse on 2023-05-08.
How many analysts cover CNK?
12 analysts have issued ratings for Cinemark Holdings, Inc. in the past 12 months.
Is CNK a buy or sell right now?
Based on 12 analyst ratings, CNK has a consensus rating of Buy (2.25/5) with a +13.6% upside to the consensus target of $31.33.
What are the earnings estimates for CNK?
Analysts estimate CNK will report EPS of $2.09 for the period ending 2026-12-31, with revenue estimated at $3.43B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.